Breast Cancer, Genetic Factors and Methods of Diagnosis

dnshnmh Srm Pub Date : 2020-02-01 DOI:10.52547/sjrm.4.4.198
A. Mohammadpour, Ehsan Jahangirian, Tamouchin Moharrami, Golnoosh Goljah Rad, Leila Javanparast Sheikhani, S. Taghizadeh
{"title":"Breast Cancer, Genetic Factors and Methods of Diagnosis","authors":"A. Mohammadpour, Ehsan Jahangirian, Tamouchin Moharrami, Golnoosh Goljah Rad, Leila Javanparast Sheikhani, S. Taghizadeh","doi":"10.52547/sjrm.4.4.198","DOIUrl":null,"url":null,"abstract":"Background and Aims: Breast cancer is the most common cancer in women. Screening, early detection, and prediction of the susceptibility are very important in drug response and choosing the appropriate treatment. Due to the limitations of conventional screening methods, such as low sensitivity and specificity, pain and anxiety, and radiation hazards of imaging techniques, use of biomarkers that can overcome these limitations would be important. Tumor markers (Protein and nucleic acid) are the most important molecular markers involved in cancer progression. About half of all hereditary breast cancers are caused by germline mutation in tumor suppressor genes and genes involved in mismatch repair, cell cycle control, steroid hormone metabolism, and cell signaling. Therefore, quantitative study of these genes can be used as a possible indicator in early detection of breast cancer. In this study, we introduce the genes involved in inherited breast cancer and the role of the main molecular techniques of its diagnosis in comparison with traditional methods. Conclusion: Various techniques such as IHC, FISH, CGH, Micro array, etc. and Molecular techniques such as RT-PCR, MLPA, QPCR, and NGS are used to measure tumor markers. Today, these techniques promise to improve diagnosis and help to select an appropriate treatment for","PeriodicalId":33200,"journal":{"name":"dnshnmh Srm","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"dnshnmh Srm","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52547/sjrm.4.4.198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background and Aims: Breast cancer is the most common cancer in women. Screening, early detection, and prediction of the susceptibility are very important in drug response and choosing the appropriate treatment. Due to the limitations of conventional screening methods, such as low sensitivity and specificity, pain and anxiety, and radiation hazards of imaging techniques, use of biomarkers that can overcome these limitations would be important. Tumor markers (Protein and nucleic acid) are the most important molecular markers involved in cancer progression. About half of all hereditary breast cancers are caused by germline mutation in tumor suppressor genes and genes involved in mismatch repair, cell cycle control, steroid hormone metabolism, and cell signaling. Therefore, quantitative study of these genes can be used as a possible indicator in early detection of breast cancer. In this study, we introduce the genes involved in inherited breast cancer and the role of the main molecular techniques of its diagnosis in comparison with traditional methods. Conclusion: Various techniques such as IHC, FISH, CGH, Micro array, etc. and Molecular techniques such as RT-PCR, MLPA, QPCR, and NGS are used to measure tumor markers. Today, these techniques promise to improve diagnosis and help to select an appropriate treatment for
癌症、遗传因素及诊断方法
背景与目的:癌症是女性最常见的癌症。药物敏感性的筛查、早期检测和预测在药物反应和选择合适的治疗中非常重要。由于传统筛查方法的局限性,如低灵敏度和特异性、疼痛和焦虑以及成像技术的辐射危害,使用能够克服这些局限性的生物标志物将是重要的。肿瘤标志物(蛋白质和核酸)是参与癌症进展的最重要的分子标志物。大约一半的遗传性乳腺癌是由肿瘤抑制基因和参与错配修复、细胞周期控制、类固醇激素代谢和细胞信号传导的基因的种系突变引起的。因此,对这些基因的定量研究可以作为癌症早期检测的可能指标。在本研究中,我们介绍了遗传性癌症的相关基因,以及与传统方法相比,主要分子技术在其诊断中的作用。结论:IHC、FISH、CGH、微阵列等多种技术和RT-PCR、MLPA、QPCR、NGS等分子技术可用于肿瘤标志物的检测。如今,这些技术有望改善诊断,并有助于选择合适的治疗方法
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信